Hepatitis B Awareness: India in the grip of hepatitis B
Hepatitis B Virus(HBV) is spreading in India at an enormous rate.About 42 million Indians suffer from the chronic Hepatitis virus infection which is responsible for 60 percent of the liver cancer cases in India.
According to Dr. Arul Prakash, leading gastroenterologist MIOT hospital that not even 1 percent of the school going children has been vaccinated against HBV.
He said “This is more shocking since there are effective vaccines available all over the world. Though a vaccine against this chronic disease was developed in 1970, we are yet to take HBV seriously.”
A team has been prepared to spread the awareness program against HBV, the disease which is defined as more worse as HIV/AIDS.
Dr. PVA Mohandas, director of MIOT hospital said “What is worrying is the fact that 40 percent of the people suffering from Hepatitis B will end up in end in cirrhosis and liver cancer.
Doctors further says that not only Hepatitis B, but its other forms such as C,D,E are also dangerous and need special attention too.They also emphasis on the fact that it is essential to identify the early symptoms of the disease so as to stop the conditions becoming worse than ever.
” The information here is for general purpose, please consult your doctor before taking any medication/therapy.”
Chronic disease management (CDM), a phrase common to people living with chronic disease, jumped from the pages of reports on primary health as far back as 1978 and onto the lexicon of elected officials around the time of the 2003 First Ministers’ Accord on Health Care Renewal. CDM is rooted in primary health care, and primary care is the foundation of Canada’s health care system. One of the focus areas for developing strategies for advancing health care renewal at the primary level is by early detection and action; the heart of which is health promotion, disease prevention and chronic disease management. In British Columbia the development of a service framework for chronic disease management centers on high-risk populations and specific chronic diseases. Arthritis and Osteoporosis is currently under development.